Gainers
- Cogent Biosciences, Inc. (NASDAQ:COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
- G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 26.9% to $0.6124 after declining 6% on Thursday.
- Regis Corporation (NYSE:RGS) jumped 24.9% to $0.6984. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations.
- Integrated Media Technology Limited (NASDAQ:IMTE) surged 18% to $3.13. Integrated Media Technology announced Memorandum of Understanding to develop sourcing channel of halal products in Thailand.
- Scopus BioPharma Inc. (NASDAQ:SCPS) gained 16% to $0.47.
- Borqs Technologies, Inc. (NASDAQ:BRQS) shares rose 15.2% to $0.1976.
- Paltalk, Inc. (NASDAQ:PALT) rose 14.4% to $2.2250 after the company acquired Visicom's ManyCam assets for $2.7 million.
- Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) gained 13.1% to $0.9613 after the company announced a buyback of up to $8 million.
- Oxbridge Re Holdings Limited (NASDAQ:OXBR) jumped 12.7% to $4.08.
- RLX Technology Inc. (NYSE:RLX) shares gained 10.7% to $2.39.
- Verona Pharma plc (NASDAQ:VRNA) surged 10.1% to $4.7231.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) gained 9.7% to $1.23 after jumping 190% on Thursday.
- Data Storage Corporation (NASDAQ:DTST) jumped 9.7% to $3.4443.
- New Oriental Education & Technology Group Inc. (NYSE:EDU) rose 9.2% to $16.08 after dropping around 15% on Thursday.
- Tenax Therapeutics, Inc. (NASDAQ:TENX) surged 8.3% to $0.6670.
- Energy Focus, Inc. (NASDAQ:EFOI) gained 8.3% to $2.48. Energy Focus recently reported a $3.5 million private placement priced at-the-market under Nasdaq rules.
Losers
- Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shares fell 58.6% to $3.35 after the company announced clinical proof-of-concept data from the ongoing Phase 1b trial of FTX-6058 for the treatment of sickle cell disease.
- Caribou Biosciences, Inc. (NASDAQ:CRBU) fell 33.5% to $5.80 after the company reported additional data from the CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.
- Comtech Telecommunications Corp. (NASDAQ:CMTL) declined 25.7% to $9.15 after the company reported worse-than-expected Q3 sales results.
- DocuSign, Inc. (NASDAQ:DOCU) shares dropped 21.4% to $68.63 after the company reported weaker-than-expected earnings results for its first quarter. The company said it expects fiscal second-quarter revenue to be between $600 million and $604 million.
- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) declined 21.2% to $0.6498 after the company announced topline clinical data for CY6463 in MELAS patients at UMDF Mitochondrial Medicine 2022 Symposium.
- Cosmos Holdings Inc. (NASDAQ:COSM) dropped 19.9% to $0.6007.
- DBV Technologies S.A. (NASDAQ:DBVT) fell 19.5% to $2.6176 after jumping around 80% on Thursday. DBV Technologies announced private placement financing of $194 million.
- Applied UV, Inc. (NASDAQ:AUVI) fell 19.4% to $2.21. Applied UV shares jumped 55% on Thursday after the company announced its distributor, M/S Novatek Pakistan, was awarded as the sole source provider of Airocide air purification systems for government hospitals.
- Wejo Group Limited (NASDAQ:WEJO) shares dropped 17.9% to $1.60. Wejo recentlyannounced the expansion and extension of its relationship with Microsoft Maps.
- View, Inc. (NASDAQ:VIEW) dipped 17.1% to $2.12.
- JanOne Inc. (NASDAQ:JAN) fell 16.6% to $3.1461. JanOne, on Thursday, said its ARCA Recycling subsidiary announced it will open three new recycling centers in June and July.
- India Globalization Capital, Inc. (NYSE:IGC) dropped 16.2% to $0.5211. IGC recently received U.S. Patent for method and composition for treating seizure disorders, utilizing CBD.
- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) fell 16.2% to $1.0809.
- 17 Education & Technology Group Inc. (NASDAQ:YQ) dipped 16.1% to $2.5588.
- Cardiff Oncology, Inc. (NASDAQ:CRDF) dropped 15.7% to $1.8950.
- Blueprint Medicines Corporation (NASDAQ:BPMC) dipped 15.3% to $49.80 after Citigroup downgraded the stock from Neutral to Sell and lowered its price target from $68 to $41.
- Stitch Fix, Inc. (NASDAQ:SFIX) shares fell 15.2% to $6.59 after the company reported worse-than-expected results for its third quarter on Thursday. The company said it sees Q4 net revenue of $485 million to $495 million.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) tumbled 15.2% to $0.2503. Sonnet BioTherapeutics recently announced results from a preclinical combination study of SON-1010 with anti-PD1 checkpoint inhibition.
- Quhuo Limited (NASDAQ:QH) fell 14% to $0.4127.
- Selecta Biosciences, Inc. (NASDAQ:SELB) declined 13.8% to $1.06.
- Stryve Foods, Inc. (NASDAQ:SNAX) dropped 13.5% to $1.09.
- Freshworks Inc. (NASDAQ:FRSH) dipped 12.8% to $12.48.
- Dave Inc. (NASDAQ:DAVE) fell 12% to $1.10.
- Pineapple Energy Inc. (NASDAQ:PEGY) fell 10.6% to $2.71.
- NextPlay Technologies, Inc. (NASDAQ:NXTP) shares fell 9.3% to $0.3177 after jumping 93% on Thursday.
- Epizyme, Inc. (NASDAQ:EPZM) fell 9.2% to $0.5941 after declining around 8% on Thursday.
- GoodRx Holdings, Inc. (NASDAQ:GDRX) fell 6.7% to $6.32. Goldman Sachs downgraded GoodRx Holdings from Buy to Neutral and lowered the price target from $12 to $9.
- U.S. Well Services, Inc. (NASDAQ:USWS) shares fell 6.3% to $0.8341 after the company announced it has received a written notice from NASDAQ that co. had failed to maintain compliance with the minimum bid requirement under Nasdaq listing rule.
